Eugenol and derivatives activity against Mycobacterium tuberculosis, nontuberculous mycobacteria and other bacteria

Papers of special note have been highlighted as: • of interest

References

• 1 WHO. Global Tuberculosis Report 2017. http://apps.who.int/iris/bitstream/10665/259366/1/9789241565516-eng.pdf?ua=1.
  Google Scholar
• 2 Covert TC, Rodgers MR, Reyes AL et al. Occurrence of nontuberculous mycobacteria in environmental samples. Appl. Environ. Microbiol. 65(6), 2492–2496 (1999).
  Medline CASGoogle Scholar
• 3 Johnson MM, Odell JA. Nontuberculous mycobacterial pulmonary infections. J. Thorac. Dis. 6(3), 210–220 (2014).
  MedlineGoogle Scholar
• 4 Maitre T, Aubry A, Jarlier V et al. Tuberculoses à bacilles multi- et ultrarésistants. Med. Mal. Infect. 47(1), 3–10 (2017).
  Medline CASGoogle Scholar
• 5 Dorman HJ, Deans SG. Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J. Appl. Microbiol. 88(2), 308–316 (2000).
  Medline CASGoogle Scholar
• 6 Ahmad A, Wani MY, Khan A et al. Synergistic interactions of eugenol-Tosylate and its congeners with fluconazole against Candida albicans. PLoS ONE 10(12), 1–19 (2015).
  Google Scholar
• 7 Ulrich-Merzenich GS. Combination screening of synthetic drugs and plant derived natural products-Potential and challenges for drug development. Synergy 1(1), 59–69 (2014).
  Google Scholar
• 8 Nejad SM. Evaluation of cytotoxicity and genotoxicity of eugenol in lymphocytes (2014). www.openaccess.hacettepe.edu.tr:8080/xmlui/bitstream/handle/11655/1142/dd98dce8-0d90-4e43-b495-5e5975b9399d.pdf?sequence=1.
  Google Scholar
• 9 Pinto E, Vale-Silva L, Cavaleiro C et al. Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. J. Med. Microbiol. 58(11), 1454–1462 (2009).
  MedlineGoogle Scholar
• 10 Leite AM, Lima EDO, De Souza EL et al. Inhibitory effect of β -pinene, α -pinene and eugenol on the growth of potential infectious endocarditis causing Gram-positive bacteria. Brazilian J. Pharm. Sci. 43(1), 121–126 (2007). • Evaluates the activity of eugenol against pathogenic bacteria that cause endocarditis.
  CASGoogle Scholar
• 11 Yadav MK, Chae S, Im GJ et al. Eugenol: a phyto-compound effective against methicillin-resistant and methicillin- sensitive Staphylococcus aureus clinical strain biofilms. PLoS ONE 10(3), 1–21 (2015). • Demonstrates that eugenol exhibits notable activity against MRSA and MSSA clinical strains biofilms.
  Google Scholar
• 12 Devi KP, Nisha SA, Sakthivel R et al. Eugenol (an essential oil of clove) acts as an antibacterial agent against Salmonella typhi by disrupting the cellular membrane. J. Ethnopharmacol. 130(1), 107–115 (2010). • Evaluates the antibacterial activity of eugenol and its mechanism of bactericidal action against Salmonella typhi.
  Medline CASGoogle Scholar
• 13 Gill AO, Holley RA. Mechanisms of bactericidal action of cinnamaldehyde against Listeria monocytogenes and of. Appl. Environ. Microbiol. 70(10), 5750–5755 (2004).
  Medline CASGoogle Scholar
• 14 Yogalakshmi B, Viswanathan P, Anuradha CV. Investigation of antioxidant, anti-inflammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats. Toxicology 268(3), 204–212 (2010).
  Medline CASGoogle Scholar
• 15 Palomino J, Martin A, Camacho M et al. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrobail Agents Chemother. 46(8), 2720–2722 (2002).
  Medline CASGoogle Scholar
• 16 CLSI. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; approved standard (2nd Edition). https://clsi.org/media/1463/m24a2_sample.pdf.
  Google Scholar
• 17 Castilho AL, Caleffi-Ferracioli KR, Canezin PH et al. Detection of drug susceptibility in rapidly growing mycobacteria by resazurin broth microdilution assay. J. Microbiol. Methods 111, 119–121 (2015).
  Medline CASGoogle Scholar
• 18 Caleffi-Ferracioli KR, Maltempe FG, Siqueira VLD et al. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method. Tuberculosis 93(6), 660–663 (2013).
  Medline CASGoogle Scholar
• 19 Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52(1), 1–1 (2003).
  Medline CASGoogle Scholar
• 20 Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63 (1983).
  Medline CASGoogle Scholar
• 21 Protopopova M, Hanrahan C, Nikonenko B et al. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1, 2-ethylenediamines. J. Antimicrob. Chemother. 56(5), 968–974 (2005).
  Medline CASGoogle Scholar
• 22 Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 1–13 (2017).
  MedlineGoogle Scholar
• 23 Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov. Today Technol. 1(4), 337–341 (2004).
  Medline CASGoogle Scholar
• 24 Nakamura de Vasconcelos SS, Caleffi-Ferracioli KR, Hegeto LA et al. Carvacrol activity & morphological changes in Mycobacterium tuberculosis. Future Microbiol. 13(8), 877–888 (2018). • This study was the reference for the chemical derivation proposal performed in the present study.
  CASGoogle Scholar
• 25 Bar FMA, Khanfar MA, Elnagar AY et al. Bioorganic & medicinal chemistry design and pharmacophore modeling of biaryl methyl eugenol analogs as breast cancer invasion inhibitors. Bioorg. Med. Chem. 18(2), 496–507 (2010).
  MedlineGoogle Scholar
• 26 Oyedemi SO, Okoh AI, Mabinya LV et al. The proposed mechanism of bactericidal action of eugenol, -terpineol and γ -terpinene against Listeria. African J. Biotechnol. 8(7), 1280–1286 (2009).
  CASGoogle Scholar
• 27 Coll P. Fármacos con actividad frente a Mycobacterium tuberculosis. Enferm. Infecc. Microbiol. Clin. 27(8), 474–480 (2009).
  MedlineGoogle Scholar
• 28 Qiu J, Feng H, Lu J et al. Eugenol reduces the expression of virulence-related exoproteins in Staphylococcus aureus. Appl. Environ. Microbiol. 76(17), 5846–5851 (2010).
  Medline CASGoogle Scholar
• 29 Mohammed MJ, Al-Bayati FA. Isolation and identification of antibacterial compounds from Thymus kotschyanus aerial parts and Dianthus caryophyllus flower buds. Phytomedicine 16(6–7), 632–637 (2009).
  Medline CASGoogle Scholar
• 30 Ryu YJ, Koh WJ, Daley CL. Diagnosis and treatment of nontuberculous mycobacterial lung disease: clinicians’ perspectives. Tuberc. Respir. Dis. (Seoul). 79(2), 74–84 (2016).
  MedlineGoogle Scholar
• 31 Chraibi M, Farah A, Lebrazi S et al. Antimycobacterial natural products from Moroccan medicinal plants: chemical composition, bacteriostatic and bactericidal profile of Thymus satureioides and Mentha pulegium essential oils. Asian Pac. J. Trop. Biomed. 6(10), 836–840 (2016).
  CASGoogle Scholar
• 32 Peruč D, Gobin I, Abram M et al. Antimycobacterial potential of the juniper berry essential oil in tap water. Arh. Hig. Rada Toksikol. 69(1), 46–54 (2018).
  MedlineGoogle Scholar
• 33 Zanetti S, Cannas S, Molicotti P et al. Evaluation of the antimicrobial properties of the essential oil of Myrtus communis L. against clinical strains of Mycobacterium spp. Interdiscip. Perspect. Infect. Dis. 2010, 1–3 (2010).
  Google Scholar
• 34 Bueno J, Escobar P, Martinez JR et al. Composition of three essential oils, and their mammalian cell toxicity and antimycobacterial activity against drug resistant-tuberculosis and nontuberculous mycobacteria strains. Nat. Prod. Commun. 6(11), 1743–1748 (2011).
  Medline CASGoogle Scholar
• 35 Jarlier V, Nikaido H. Permeability barrier to hydrophilic solutes in Mycobacterium chelonei. J. Bacteriol. 172(3), 1418–1423 (1990).
  Medline CASGoogle Scholar
• 36 Rutkowska E, Pajak K, Jóźwiak K. Lipophilicity - Methods of determination and its role in medicinal chemistry. Acta Pol. Pharm. - Drug Res. 70(1), 3–18 (2013).
  Medline CASGoogle Scholar
• 37 Sieniawska E, Sawicki R, Swatko-ossor M et al. The effect of combining natural terpenes and antituberculous agents against reference and clinical Mycobacterium tuberculosis strains. Molecules 23(176), 1–14 (2018).
  Google Scholar
• 38 Ehab AA, Galal AM, Shebl AM et al. Enhancing effect of isoeugenol on the antimicrobial activity of isoniazid, 6-paradol and 6-shogaol. J. Herbs. Spices Med. Plants 13(4), 95–103 (2008).
  Google Scholar
• 39 Hegeto LA, Caleffi-Ferracioli KR, Nakamura-Vasconcelos SS et al. In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis. Tuberculosis 111, 35–40 (2018).
  Medline CASGoogle Scholar
• 40 Barros Gomes PR, Mouchrek Filho VE, Ferreira Rabêlo W et al. Caracterização química e citotoxicidade do óleo essencial do cravo-da-índia (Syzygium aromaticum). Rev. Colomb. Ciencias Químico-Farmacéuticas. 47(1), 37–52 (2018).
  Google Scholar